<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date14837210.5 (espacenet)  (Federated)  (European Patent Register), 20140822
Patent/reg. no. and dateDK/EP 3037424, 20171108
Publication date20160629
Priority no. and dateJP 2013172746, 20130822
EP pub. no. and date EP 3037424 20160629
Effective date
Applicant/ownerTaiho Pharmaceutical Co., Ltd., 1-27 Kandanishiki-cho Chiyoda-ku
Tokyo 101-8444, JP
Applicant ref. no.P63083DK01
InventorNONOSHITA, Katsumasa, c/o TAIHO PHARMACEUTICAL CO. LTD.
3 Okubo
Tsukuba-shi
Ibaraki 300-2611, JP,
UNO, Takao, c/o TAIHO PHARMACEUTICAL CO. LTD.
3 Okubo
Tsukuba-shi
Ibaraki 300-2611, JP,
SHIMAMURA, Tadashi, c/o TAIHO PHARMACEUTICAL CO. LTD.
3 Okubo
Tsukuba-shi
Ibaraki 300-2611, JP
RepresentativePlougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK
Opponent
IPC ClassA61K 31/519 (2006.01) , A61K 31/55 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) , C07D 487/14 (2006.01) 
TitleNY QUINOLIN-SUBSTITUERET FORBINDELSE
Int. application no.JP2014071951
Int. publication no.WO2015025936
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact